Liminatus Pharma, Inc. Class A Common Stock (LIMN)

NASDAQ:LIMN

Liminatus Pharma, Inc. Class A Common Stock

—

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.

2025

Founded

Country

—

CEO

—

Fulltime Employees

-0.24

PE Ratio

-0.01

Relative PE Ratio

0.00%

Dividend Yield

USD 0.10

Stock Price

+4.15%

1D Change

USD 4.85

52W High

USD 0.10

52W Low

52W Range

$2,446.62K

Market Cap

Revenue

$-10,206.52K

Net Income

Net Margin

$1,907.67K

Cash

$1,442.50K

Debt

$1,981.44K

Enterprise Value

$-2,967.81K

Operating Profit

$-9,963.32K

Operating Cash Flow

$13.11K

CapEx

$-9,976.43K

Free Cash Flow

-515.11 %

Net Income / EV

-502.83 %

OCF / EV

-503.49 %

FCF / EV

Actions

Website Investor Relations

AI Actions

Moat Analysis Key business risks Management Analysis Balance Sheet Analysis Normalize Earnings Growth Drivers Capital Allocation Latest News

—

Daily adjusted close

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.

2025

Founded

Country

—

CEO

—

Fulltime Employees

0 USD

Revenue

-10.21M USD

Net Income

Net Margin

0.00%

Dividend Yield

-0.24

PE Ratio

-0.01

Relative PE Ratio

$4.85

52W High

$0.10

52W Low

52w Range

2.45M USD

Market Cap

1.91M USD

Cash

1.44M USD

Debt

1.98M USD

Enterprise Value

-2.97M USD

Operating Profit

-9.96M USD

Operating Cash Flow

13.11K USD

CapEx

-9.98M USD

Free Cash Flow

-515.11 %

Net Income / EV

-502.83 %

OCF / EV

-503.49 %

FCF / EV

Actions

Website Investor Relations

AI Actions

Explain Business Moat Analysis Key business risks Management Analysis Balance Sheet Analysis Normalize Earnings Growth Drivers Dividend Track Record Capital Allocation Latest News

$LIMN

Liminatus Pharma, Inc. Class A Common Stock

-515.11 %

Net Income / EV

-502.83 %

Operating Cash Flow / EV

-503.49 %

Free Cash Flow / EV

Key stats based on share price of USD 0.10, as of 7, August 2026.

View more and calculate expected returns for free on www.aiir.finance

AIIR Finance

Key Stats

Market Cap$2,446.62K

- Cash$1,907.67K

+ Debt$1,442.50K

Enterprise Value$1,981.44K

Revenue$0

Gross Profit_

Operating Profit$-2,967.81K

Net Income$-10,206.52K

Operating Cash Flow$-9,963.32K

CapEx$13.11K

Free Cash Flow$-9,976.43K

Net Income / EV-515.11 %

OCF / EV-502.83 %

FCF / EV-503.49 %